What does this procedure involve?

This treatment combines Intensity-Modulated Radiation Therapy (IMRT) with concurrent cisplatin chemotherapy for nasopharyngeal carcinoma (NPC). IMRT delivers precisely shaped radiation beams to the tumor while sparing nearby healthy tissues, such as the salivary glands and spinal cord. The protocol consists of 33 daily fractions (Monday through Friday) over approximately seven weeks, with weekly intravenous cisplatin infusions. The cisplatin acts as a radiosensitizer, making cancer cells more vulnerable to radiation. This concurrent approach is considered a standard of care for locoregionally advanced NPC.